We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Acrongenomics and Molecular Vision Demonstrates BioLED Lab on a Chip Technology
News

Acrongenomics and Molecular Vision Demonstrates BioLED Lab on a Chip Technology

Acrongenomics and Molecular Vision Demonstrates BioLED Lab on a Chip Technology
News

Acrongenomics and Molecular Vision Demonstrates BioLED Lab on a Chip Technology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Acrongenomics and Molecular Vision Demonstrates BioLED Lab on a Chip Technology"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Acrongenomics, Inc. and Molecular Vision, Ltd. (MLV) an Imperial College spin-out company, have announced the demonstration of their BioLED Lab on a Chip technology using MVL’s patented, organic semiconductor technology in a high sensitivity, small size, medical diagnostic device that took place at Imperial College in London, UK on March 8th 2007.

The device has demonstrated its technological capability to measure biomarkers with high sensitivity.

BioLED technology uses semiconductor films located on either side of a microfluidics chip. One film illuminates the chip, where appropriate, while the other film detects an output signal, which is fed to a display.

The demonstrated device used two forms of detection utilizing chemiluminescence and fluorescence to detect different markers of interest.

Acrongenomics & Molecular Vision believe that this technology is capable of further miniaturization along with large scale, low cost manufacturing, which will bring forward disposable, Point Of Care diagnostics for a large range of biomarkers.

Furthermore the companies presented possible design concepts of BioLED technology applications to be used at home, in doctor’s offices and hospitals.

Advertisement